Steven Favaloro

Genezen Laboratories, Inc. is a company based in Indianapolis, IN that was founded in 2014 by Bill Vincent. Genezen Laboratories has expansive knowledge and experience in the industry and works with the nation's leading institutions. The company is focused on supporting the demands of the current and future gene and cell therapy manufacturing market worldwide. The company offers early-phase process development, GMP vector production, and analytical testing services to both early-stage, growth-oriented companies and established industry leaders. Steven J. Favaloro has been the CEO of the company since 2023.

Ampersand Management LLC (Ampersand Management) is a private equity firm founded in 1988 by Richard A. Charpie. The firm is headquartered in Wellesley, Massachusetts.

Arbor Biotechnologies, Inc. engages in curating genetic biodiversity and discover novel protein functions from nature. The company was founded by David Arthur Svott, Winston Xia Yan, Feng Zhang and David R. Walt in 2016 and is headquartered in Cambridge, MA.

Arranta Bio Holdings LLC engages in the provision of contract development and manufacturing services for therapies targeting diseases linked to the human microbiome. It offers media formulation, cell banking, fermentation, cell harvest and downstream process, formulation, lyophilization, drug product finishing, and analytical services. The company was founded by Mark R. Bamforth and Iain Baird in May 2019 and is headquartered in Watertown, MA.

Brammer Bio LLC manufactures pharmaceutical products. The firm’s services include process development, gene therapy manaufacturing and viral vectors. The company was founded by Christopher K. Murphy, Richard O. Snyder, Mark R. Bamforth and Steven H. Kasok in 2015 and is headquartered in Cambridge, MA.